Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
View ORCID ProfileSonia M Vallabh, View ORCID ProfileEric Vallabh Minikel, Victoria J Williams, Becky C Carlyle, Alison J McManus, Chase D Wennick, Anna Bolling, Bianca A Trombetta, David Urick, Chloe K Nobuhara, Jessica Gerber, Holly Duddy, Ingolf Lachmann, Christiane Stehmann, Steven J Collins, Kaj Blennow, Henrik Zetterberg, Steven E Arnold
doi: https://doi.org/10.1101/2019.12.13.19014217
Sonia M Vallabh
1Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
3Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA
4Prion Alliance, Cambridge, MA, 02139, USA
Eric Vallabh Minikel
1Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
3Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, 02142, USA
4Prion Alliance, Cambridge, MA, 02139, USA
Victoria J Williams
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Becky C Carlyle
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Alison J McManus
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Chase D Wennick
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Anna Bolling
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Bianca A Trombetta
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
David Urick
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Chloe K Nobuhara
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Jessica Gerber
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Holly Duddy
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
Ingolf Lachmann
5AJ Roboscreen GmbH, Leipzig, 04129, Germany
Christiane Stehmann
6Australian National CJD Registry, University of Melbourne, Parkville, 3010, Australia
Steven J Collins
6Australian National CJD Registry, University of Melbourne, Parkville, 3010, Australia
Kaj Blennow
7Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, S-431 80, Sweden
Henrik Zetterberg
7Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, S-431 80, Sweden
8Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden
9UK Dementia Research Institute, University College London, London, WC1N 3BG, UK
10Department of Molecular Neuroscience, UCL Institute of Neurology, London, WC1N 3BG, UK
Steven E Arnold
1Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, 02114, USA
2Department of Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
R source code for this study is available in a public repository: https://github.com/ericminikel/mgh_prnp_fluid_biomarkers De-identified data will be made available to qualified investigators upon request.
Posted December 15, 2019.
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
Sonia M Vallabh, Eric Vallabh Minikel, Victoria J Williams, Becky C Carlyle, Alison J McManus, Chase D Wennick, Anna Bolling, Bianca A Trombetta, David Urick, Chloe K Nobuhara, Jessica Gerber, Holly Duddy, Ingolf Lachmann, Christiane Stehmann, Steven J Collins, Kaj Blennow, Henrik Zetterberg, Steven E Arnold
medRxiv 2019.12.13.19014217; doi: https://doi.org/10.1101/2019.12.13.19014217
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease
Sonia M Vallabh, Eric Vallabh Minikel, Victoria J Williams, Becky C Carlyle, Alison J McManus, Chase D Wennick, Anna Bolling, Bianca A Trombetta, David Urick, Chloe K Nobuhara, Jessica Gerber, Holly Duddy, Ingolf Lachmann, Christiane Stehmann, Steven J Collins, Kaj Blennow, Henrik Zetterberg, Steven E Arnold
medRxiv 2019.12.13.19014217; doi: https://doi.org/10.1101/2019.12.13.19014217
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (719)
- Anesthesia (214)
- Cardiovascular Medicine (3041)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12962)
- Forensic Medicine (12)
- Gastroenterology (848)
- Genetic and Genomic Medicine (4772)
- Geriatric Medicine (440)
- Health Economics (747)
- Health Informatics (3028)
- Health Policy (1095)
- Hematology (405)
- HIV/AIDS (952)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (490)
- Neurology (4544)
- Nursing (242)
- Nutrition (671)
- Oncology (2364)
- Ophthalmology (666)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (296)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1231)
- Primary Care Research (515)
- Public and Global Health (7135)
- Radiology and Imaging (1587)
- Respiratory Medicine (940)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (504)
- Toxicology (63)
- Transplantation (218)
- Urology (187)